600535:SHA
Tasly Pharmaceutical Group Co Ltd
CN¥ १४.०४
arrow_downward
-०.३५%(-०.०५०) 1D
अक्टोबर १६, १५:००:०० GMT+८ · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600535...
Open
CN¥ १४.१८
High
CN¥ १४.३५
Low
CN¥ १३.९२
Mkt. cap
२१.०५ अरब
Avg. vol.
१.१४ करोड
Volume
१.५७ करोड
Dividend
२.४२%
Quarterly dividend
CN¥ ०.०९
Ex-dividend date
२०२६ मे २९
P/E ratio
१७.१५
52-wk high
CN¥ १६.२४
52-wk low
CN¥ १२.९०
EPS
CN¥ ०.८२
Shares outstanding
१.५१ अरब
No. of employees
११ हजार
Open
CN¥ १४.१८
High
CN¥ १४.३५
Low
CN¥ १३.९२
Mkt. cap
२१.०५ अरब
Avg. vol.
१.१४ करोड
Volume
१.५७ करोड
Dividend
२.४२%
Quarterly dividend
CN¥ ०.०९
Ex-dividend date
२०२६ मे २९
P/E ratio
१७.१५
52-wk high
CN¥ १६.२४
52-wk low
CN¥ १२.९०
EPS
CN¥ ०.८२
Shares outstanding
१.५१ अरब
No. of employees
११ हजार
Related stocks
News stories
From web sources and news partners
Simply Wall Street
·
७ मिनेट पहिले
Raised Outlook Change The Bull Case For Neogen (NEOG)?
The Motley Fool
·
२३ मिनेट पहिले
Missing the S&P 500's 10 Best Days in 20 Years Cut a $10,000 Investment's Ending Value by More Than Half
ChartMill
·
४० मिनेट पहिले
HONGLI GROUP INC (NASDAQ:HLP) Passes Minervini Trend Template and High-Growth Momentum Screen
MarketWatch
·
१२ घण्टा पहिले
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profile
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
About Tasly Pharmaceutical Group Co Ltd